This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Peptides & Oligonucleotides

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Events

Showing 4 of 13 eventsView all events

Oligonucleotide Conjugate Strategies

April 25-27, 2023
, Online Training Course

Understand how to best design Oligonucleotide conjugates from simple starting building blocks to the full oligonucleotide conjugate

Influenza mRNA Vaccines

April 27, 2023
, 8:00AM EDT // 1:00PM BST // 2:00PM CEST

Next generation mRNA approaches: efficacious vaccines for improved influenza immunity

TIDES USA: Oligonucleotide & Peptide Therapeutics

May 7-10, 2023 | In-Person + Digital
, Manchester Grand Hyatt San Diego

Industry’s Largest & Most Renowned Event to Accelerate Your Oligo and Peptide Therapeutics to Market: Leading Strategies for Expediting R&D and Improving CMC Efficiency

Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides

Online Training Course

LEARN HOW TO DEVELOP AN EVOLVING ANALYTICAL CONTROL STRATEGY FOR YOUR OLIGONUCLEOTIDE DRUG SUBSTANCE

Articles & Video

Showing 9 of 78 articles & videoView all articles & video
Featured
Drug Delivery

Delivery Systems and Strategies for Oligonucleotide Therapeutics

We explore key challenges and solutions in oligo-based drug delivery found in leading programs in the industry.
Featured
Peptides and Oligonucleotides

Report: Oligonucleotide, Peptide, mRNA and Genome Edited Therapeutics State of the Industry 2021

How has the oligonucleotide, peptide, mRNA and genome editing sector transformed over the last year? This industry report provides insight.
Oligonucleotides

Honeywell Scales with Customers’ Oligo Synthesis Requirements

Analytical Chemistry

Analytical Strategies for Oligonucleotide and Peptide Therapeutics - TIDES eBook Series

This TIDES eBook focuses on the challenges, strategies and technologies for measuring quality of oligonucleotides and peptides in therapeutic development.
Tides

TIDES TV Interview with Dr. Martin Rabel, Precision NanoSystems

CMC

Chemistry, Manufacturing, and Control Strategies for Peptides and Oligonucleotides

Drug Manufacturing

Innovations by PeptiStar for Middlemolecule Drug Substance Manufacturing

Drug Delivery

Targeted Delivery of Oligonucleotides: Tissue-specific Challenges and Novel Conjugation

Oligonucleotides

Rapid characterization of oligonucleotides using microfluidic capillary electrophoresis

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 40,000+ TIDES executives and scientists, including 2,000+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Michael Dunnet, Head of Portfolio Sales:
michael.dunnet@informa.com | +1 (857) 504-6732

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Copyright © 2022 Informa Connect Limited. Registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.